A new mutation in the Parkinson's‐related FBXO7 gene impairs mitochondrial and proteasomal function
The FEBS Journal · 2024
DOI: 10.1111/febs.17155 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Elisa Navarro und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Medicine, Neurochemistry Research Institute, Complutense University of Madrid, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Proteasome Endopeptidase Complex, F-Box Proteins, Mitochondria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Around 10% of Parkinson's disease (PD) cases are associated with mutations in various genes, including FBXO7 , which encodes the substrate‐recognition component for the Skp1‐Cullin‐F‐box (SCF) class of ubiquitin E3 ligases that target proteins for proteasomal degradation. In their recent study, Al Rawi et al . characterized a new mutation in FBXO7 , L250P, in a pediatric patient. Their findings reveal that the L250P mutation abolishes Fbxo7 interaction with the proteasome regulator, proteasome inhibitor 31kD (PI31), affecting proteasomal activity and the ubiquitination of some of the ligase's targets. Furthermore, the authors show that this previously undescribed mutation impairs mitochondrial function and mitophagy, emphasizing the importance of mitochondrial and proteasomal dysfunction in PD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Medicine, Neurochemistry Research Institute, Complutense University of Madrid, Spain.
- CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain.
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), Madrid, Spain.
ORCID-Profile: Elisa Navarro, Noemí Esteras
Förderung
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Navarro, E., & Esteras, N. (2024). A new mutation in the Parkinson's‐related FBXO7 gene impairs mitochondrial and proteasomal function. The FEBS Journal. https://doi.org/10.1111/febs.17155
Vancouver
Navarro E, Esteras N. A new mutation in the Parkinson's‐related FBXO7 gene impairs mitochondrial and proteasomal function. The FEBS Journal. 2024. doi:10.1111/febs.17155
BibTeX
@article{Navarro2024,
author = {Navarro, Elisa and Esteras, Noemí},
title = {A new mutation in the Parkinson's‐related FBXO7 gene impairs mitochondrial and proteasomal function},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17155}
}
EUVIMED